Rice Hall James & Associates LLC Lowers Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Rice Hall James & Associates LLC decreased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 573,534 shares of the company’s stock after selling 18,723 shares during the period. Prestige Consumer Healthcare accounts for 2.2% of Rice Hall James & Associates LLC’s holdings, making the stock its 8th biggest position. Rice Hall James & Associates LLC owned 1.16% of Prestige Consumer Healthcare worth $41,352,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Boston Trust Walden Corp acquired a new stake in shares of Prestige Consumer Healthcare during the third quarter worth $41,785,000. Ariel Investments LLC lifted its position in Prestige Consumer Healthcare by 10.7% during the 2nd quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock worth $195,204,000 after acquiring an additional 274,212 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Prestige Consumer Healthcare by 26.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company’s stock valued at $90,891,000 after purchasing an additional 272,773 shares during the last quarter. Victory Capital Management Inc. increased its holdings in shares of Prestige Consumer Healthcare by 9.0% in the second quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock valued at $142,827,000 after purchasing an additional 171,357 shares during the period. Finally, F M Investments LLC purchased a new position in shares of Prestige Consumer Healthcare in the second quarter worth about $11,162,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on PBH shares. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson upped their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $94.20.

Prestige Consumer Healthcare Trading Up 0.3 %

Shares of Prestige Consumer Healthcare stock opened at $73.75 on Friday. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.61 and a fifty-two week high of $75.80. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23. The company has a market cap of $3.66 billion, a P/E ratio of 18.03, a price-to-earnings-growth ratio of 2.08 and a beta of 0.47. The firm has a 50-day simple moving average of $72.12 and a two-hundred day simple moving average of $69.52.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The company had revenue of $267.10 million during the quarter, compared to analysts’ expectations of $260.54 million. During the same quarter in the prior year, the firm posted $1.06 EPS. Prestige Consumer Healthcare’s quarterly revenue was down 4.4% compared to the same quarter last year. As a group, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.